Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

3421. Costs and benefits of cervical screening. II: Is it worthwhile reducing the screening interval from 5 to 3 years?

Costs and benefits of cervical screening. II: Is it worthwhile reducing the screening interval from 5 to 3 years? Costs and benefits of cervical screening. II: Is it worthwhile reducing the screening interval from 5 to 3 years? Costs and benefits of cervical screening. II: Is it worthwhile reducing the screening interval from 5 to 3 years? Waugh N, Robertson A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract (...) contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Reducing the cervical screening interval from 5 to 3 years. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Women aged 20-64 years undergoing cervical screening. Setting Hospital. The economic study was set in Tayside, UK. Dates to which data relate Effectiveness

1996 NHS Economic Evaluation Database.

3422. Prenatal screening for Down's syndrome using inhibin-A as a serum marker

Prenatal screening for Down's syndrome using inhibin-A as a serum marker Prenatal screening for Down's syndrome using inhibin-A as a serum marker Prenatal screening for Down's syndrome using inhibin-A as a serum marker Wald N J, Densem J W, George L, Muttukrishna S, Knight P G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Inhibin-a serum marker with human chorionic gonadotrophin, alpha-fetoprotein (AFP), and unconjugated oestriol (uE3) used in prenatal screening for Down's syndrome. Type of intervention Primary prevention and screening. Economic study type Cost-effectiveness analysis. Study population Caucasian pregnant women. Setting Hospital. The economic study was carried out in London, UK. Dates to which data

1996 NHS Economic Evaluation Database.

3423. A comparison of the case-finding effectiveness and average costs of screening and partner notification

A comparison of the case-finding effectiveness and average costs of screening and partner notification A comparison of the case-finding effectiveness and average costs of screening and partner notification A comparison of the case-finding effectiveness and average costs of screening and partner notification Oxman G L, Doyle L Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Two case-finding methods - screening and partner notification - to control syphilis in an epidemic situation. Serologic testing for syphilis was implemented or enhanced in the study county health department's sexually transmitted disease (STD) and primary care clinics, local jails, and a variety of community clinics and outreach sites. A Venereal Disease

1996 NHS Economic Evaluation Database.

3424. Cost-effectiveness of HIV screening in acute care settings

Cost-effectiveness of HIV screening in acute care settings Cost-effectiveness of HIV screening in acute care settings Cost-effectiveness of HIV screening in acute care settings Owens D, Nease R, Harris R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions (...) drawn. Health technology HIV screening in acute care settings. Type of intervention Screening. Economic study type Cost-effectiveness analysis and cost-utility analysis. Study population The base case assumed a 30 year old with a sexual partner of the same age, and a 1% prevalence of HIV infection among patients. Further, the probability of infecting a sexual partner (per 3 month period) male to female = 1.04%, and female to male = 0.23%. The base case assumed that the individual had only one

1996 NHS Economic Evaluation Database.

3425. Cost-effectiveness of routine screening for proximal deep venous thrombosis in acquired brain injury patients admitted to rehabilitation

Cost-effectiveness of routine screening for proximal deep venous thrombosis in acquired brain injury patients admitted to rehabilitation Cost-effectiveness of routine screening for proximal deep venous thrombosis in acquired brain injury patients admitted to rehabilitation Cost-effectiveness of routine screening for proximal deep venous thrombosis in acquired brain injury patients admitted to rehabilitation Meythaler J M, De Vivo M J, Hayne J B Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Routine ultrasound screening for proximal deep venous thrombosis (DVT). Techniques used were real time, spectral Doppler, and colour Doppler ultrasound. Type of intervention Screening; Secondary prevention. Economic study type Cost

1996 NHS Economic Evaluation Database.

3426. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre

Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre Manus B, Bragelmann R, Armbrecht U, Stolte M, Stockbrugger R W Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Faecal occult blood testing (FOBT) and primary sigmoidoscopy in screening for gastrointestinal neoplasia. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population The study population was symptomatic

1996 NHS Economic Evaluation Database.

3427. Cost-effectiveness of one-stage ultrasound screening in pregnancy: a report from the Helsinki ultrasound trial

Cost-effectiveness of one-stage ultrasound screening in pregnancy: a report from the Helsinki ultrasound trial Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

1996 NHS Economic Evaluation Database.

3428. A cost-effectiveness evaluation of new-born hemoglobinopathy screening from the perspective of state health care systems

A cost-effectiveness evaluation of new-born hemoglobinopathy screening from the perspective of state health care systems A cost-effectiveness evaluation of new-born hemoglobinopathy screening from the perspective of state health care systems A cost-effectiveness evaluation of new-born hemoglobinopathy screening from the perspective of state health care systems Gessner B D, Teutsch S M, Shaffer P A Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Four hemoglobinopathy screening strategies for new-borns to prevent adverse outcomes of sickle cell disease (SCD) from the perspective of state health care systems. The four strategies were as follows: targeted screening with complete follow-up (TCSF), universal screening

1996 NHS Economic Evaluation Database.

3429. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women

A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women Genc M, Mardh P A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract (...) contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology A 'no screening' strategy, screening with tissue cell culture, confirmed enzyme immunoassay, and DNA amplification assays based on either polymerase chain reaction or ligase chain reaction as well as treatment with either a single dose of azithromycin or standard 7-day, twice daily doxycyline were considered

1996 NHS Economic Evaluation Database.

3430. Targeted screening for diabetes in community chiropody clinics

Targeted screening for diabetes in community chiropody clinics Targeted screening for diabetes in community chiropody clinics Targeted screening for diabetes in community chiropody clinics Gill G V, Lishman M, Kaczmarczyk E, Tesfaye S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Screening for diabetes mellitus using urine glucose self-testing, backed up with glucose tolerance tests (GTT). Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Patients, aged between 40 and 75 years and without previously diagnosed diabetes, attending a community chiropody clinic. Setting Community. The study was carried out in Liverpool, UK. Dates to which data relate Not reported. The study

1996 NHS Economic Evaluation Database.

3431. Cost-effectiveness of ultrasonographic screening for congenital hip dysplasia in new-borns

Cost-effectiveness of ultrasonographic screening for congenital hip dysplasia in new-borns Cost-effectiveness of ultrasonographic screening for congenital hip dysplasia in new-borns Cost-effectiveness of ultrasonographic screening for congenital hip dysplasia in new-borns Geitung J T, Rosendahl K, Sudmann E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Ultrasonographic screening for congenital hip dysplasia (CDH) in new-borns. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population The study population, for the purposes of assessing ultrasonographic screening, consisted of a hypothetical cohort of all new-born infants in the hospital in which the study was conducted. A second

1996 NHS Economic Evaluation Database.

3432. Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests

Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests Farnham P G, Gorsky R D, Holtgrave D R, Jones W K, Guinan M E Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) ,was not tested by sensitivity analysis. g) A calculation of the incremental cost-effectiveness ratio between the current and rapid C/T procedure would have been helpful, since rapid C/T has been shown to be more expensive and more effective than the current procedure. Bibliographic details Farnham P G, Gorsky R D, Holtgrave D R, Jones W K, Guinan M E. Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests. Public Health Reports 1996; 111(1): 44-53

1996 NHS Economic Evaluation Database.

3433. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis

Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis Danese M D, Powe N R, Sawin C T, Ladenson P W Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Measuring serum thyroid stimulating hormone (TSH) in the screening for mild thyroid failure (MTF) for individuals aged 35-years and over. Type of intervention Screening. Economic study type Cost-utility analysis. Study population Men and women screened every 5 years (during the periodic

1996 NHS Economic Evaluation Database.

3434. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age

Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age Briggs A H, Sculpher M J, Logan R P H, Aldous J, Ramsay M E, Baron J H Record Status (...) This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Helicobacter pylori (HP) screening and treatment using triple eradication therapy based on bismuth, in dyspeptic patients under 45 years of age. Type of intervention Screening and treatment. Economic study type

1996 NHS Economic Evaluation Database.

3435. Cost effectiveness of screening for primary open angle glaucoma

Cost effectiveness of screening for primary open angle glaucoma Cost effectiveness of screening for primary open angle glaucoma Cost effectiveness of screening for primary open angle glaucoma Boivin J F, McGregor M, Archer C Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Primary open glaucoma screening. Type of intervention Primary prevention; screening. Economic study type Cost-effectiveness analysis. Study population The study population modelled included all people in age ranges 40-79 years and 65-79 years. Setting The setting was a hypothetical community-wide screening of people in Quebec, Canada. Dates to which data relate Effectiveness data were obtained between 1988-1993. Resource and cost data were obtained

1996 NHS Economic Evaluation Database.

3436. Cost-effectiveness of cancer screening in end-stage renal disease

Cost-effectiveness of cancer screening in end-stage renal disease Cost-effectiveness of cancer screening in end-stage renal disease Cost-effectiveness of cancer screening in end-stage renal disease Chertow G M, Paltiel A D, Owen W F, Lazarus J M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology Cancer diagnostic tests (mammography, papanicolaou, flexible sigmoidoscopy and prostate-specific antigen) for End Stage Renal Disease (ESRD) patients. Type of intervention Screening and treatment. Economic study type Cost-effectiveness analysis. Study population Hypothetical cohort of patients with ESRD aged 30-85 and the general population with respect to four cancer types and four ethnicnder categories: breast cancer (white females

1996 NHS Economic Evaluation Database.

3437. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials

Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials Parsonnet J, Harris R A, Hack H M, Owens D K Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening for H. Pylori at age 50 and treatment for those with a positive test as a gastric cancer prevention strategy. Type of intervention Screening and treatment. Economic study type Cost-effectiveness analysis. Study population Individuals aged 50 years. Setting Hospital

1996 NHS Economic Evaluation Database.

3438. Cost-effectiveness of interventions to promote cervical screening in general practice

Cost-effectiveness of interventions to promote cervical screening in general practice Cost-effectiveness of interventions to promote cervical screening in general practice Cost-effectiveness of interventions to promote cervical screening in general practice Hyndman J C, Straton J A, Pritchard D A, Le Sueur H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Interventions to extend the take-up of cervical screening in general practice. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Women, aged 36 to 69 years, who were eligible for a Pap smear. Setting General practice. The study was set in Perth, Australia. Dates to which data relate Effectiveness, resource use, and cost data

1996 NHS Economic Evaluation Database.

3439. Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease

Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease Derdeyn C P, Powers W J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical (...) assessment on the reliability of the study and the conclusions drawn. Health technology Using Doppler ultrasound as a screening tool for asymptomatic carotid atherosclerotic disease to select subjects for arteriography and subsequent surgery. Type of intervention Screening and treatment. Economic study type Cost-utility analysis. Study population The study population was a hypothetical cohort of asymptomatic men aged 60 years. Two different sub-population were the focus of the study:a population

1996 NHS Economic Evaluation Database.

3440. Unlinked anonymous HIV screening of pregnant women in a low-prevalence population

Unlinked anonymous HIV screening of pregnant women in a low-prevalence population Unlinked anonymous HIV screening of pregnant women in a low-prevalence population Unlinked anonymous HIV screening of pregnant women in a low-prevalence population Kantanen M L, Koskela P, Leinikki P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Unlinked anonymous HIV screening in pregnant women using an EIA test (Biotest Anti-HIV-1/-2 Recombinant) on pools of 5 sera. Type of intervention Screening; Diagnosis. Economic study type Cost-effectiveness analysis. Study population Pregnant women from Finland.66,170 serum samples, covering more than 99% of pregnant women were tested in pools of 5 sera. Setting Laboratory/Hospital. The economic

1996 NHS Economic Evaluation Database.